Dr. Chad Crystal, CEOTo date, ERA has participated in approximately 150 clinical studies across multiple therapeutic areas, demonstrating depth of experience and operational consistency that sponsors and CROs depend on. These studies span blood manipulation therapies, neurology and cognitive decline, and AI-powered cardiac imaging, along with established strengths in diabetes, obesity, GLP-1 receptor agonists, and hospital-based point-of-care research.
Sponsors and CROs rely on ERA to execute even the most complex protocols, including helping to support those seeking 510(k) approval, all thanks to its full-time principal investigators and highly trained nurse coordinators who combine deep clinical expertise with patient-focused engagement.
ERA’s model is unique: the organization integrates Registered Nurses (RNs) directly into its recruiting team, leveraging their medical expertise to carefully identify and screen the most appropriate participants for each study. These RNs work alongside physicians to assess inclusion and exclusion criteria, ensure safety, and optimize participant suitability—improving data integrity, patient outcomes, and overall study performance.
We ensure patients receive exceptional care and sponsors experience seamless and reliable clinical trial execution.
ERA excels at identifying and recruiting a broad range of study participants, ensuring strong representation across all ethnicities and backgrounds. This commitment to inclusion enhances data diversity and relevance, producing more accurate and representative results that better reflect real-world populations. Sponsors recognize ERA’s ability to meet diversity goals while maintaining precision, compliance, and patient care excellence.
This physician-led structure differentiates ERA from traditional research sites that depend on part- time or third-party staff. Full-time investigators ensure that trials stay on schedule, deviations remain under 3 percent, and queries are answered within 48 hours. The combination of physician leadership, skilled nurse coordinators, RN-driven recruiting practices, and inclusive enrollment strategies drives patient retention above 99 percent and enables ERA to consistently achieve top national enrollment rankings for both hospital-based point-of-care studies and complex pharmaceutical/device trials.
Built on transparency and selectivity, ERA only undertakes trials it can execute successfully, prioritizing quality over quantity. This approach creates consistently high-value outcomes, extending sponsor relationships and often securing additional or larger studies. Many patients return for multiple trials—some completing a dozen—reflecting deep satisfaction and trust.
“We ensure patients receive exceptional care and sponsors experience seamless and reliable clinical trial execution,” states CEO Dr. Chad Crystal.
ERA’s reach has grown dramatically over the past six years, from a single 1,500-square-foot site to a 10,000-square-foot freestanding research center with multiple collaborative locations. In Washington, ERA partners with pediatric and cardiology groups and conducts research directly from emergency departments. In West Texas, through partnerships with hospitals, primary care clinics, urgent care centers, and cardiologists, ERA now serves Midland and Odessa as the region’s largest dedicated research provider—bringing advanced therapies to communities previously underserved.
Looking ahead, ERA is expanding in cardiology and cognitive health while strengthening its capability to deliver cutting-edge trials such as AI-enabled imaging, blood manipulation, and 510(k) pathway device research. The team’s proven ability to exceed enrollment targets, maintain exceptional data integrity, and retain patients positions ERA as the partner of choice for sponsors and CROs seeking reliable, high-performance trial execution.
Grounded in physician-led expertise, operational excellence, and a patient-centered ethos, ERA Health Research unlocks access to advanced therapies for communities that need them most—delivering measurable value for sponsors, providers, and patients alike.
Medical Research Services That Move Trials From Promise to Proof
Life science companies invest in medical research services to generate reliable evidence that meets scientific, regulatory and commercial standards. Even with a strong protocol and committed sponsors, trials can lose momentum if enrollment slows, site coordination weakens or patient retention drops after screening begins.
To clinical managers overseeing timelines, sponsors and evidence, the correct research partner is an operational arm of the trial strategy-translating the protocol design into eligible enrollment, diligent conduct and predictable trial outcomes.
This challenge becomes especially important in therapeutic areas where patient eligibility is narrow and recruitment requires clinical judgment rather than mass outreach. Studies involving diabetes, obesity, cardiovascular disease, metabolic disorders and medical devices often depend on careful interpretation of medication histories, comorbidities, visit requirements and patient concerns. Recruitment quality matters as much as recruitment speed.
Good research providers know and communicate where they can actually enroll subjects and where they can't. This prevents sponsors from wasting money and time on sites that will never achieve a realistic enrollment rate. Over-promising will likely speed up the startup on paper, but non-performing sites will cost more time and money later.
Speed is still important, especially in competitive clinical development landscapes. The sponsors and CROs are in search of a partner that would accelerate the study from initial contact to contract, from contracted to budget to first patient, to FPI. However, a rapid start is not beneficial unless paired with good screening, effective investigators and maintenance of participants throughout the study period.
The best-performing sites typically combine multiple operational strengths: trained clinical recruiters, dedicated principal investigators, established referral networks and patient communication systems designed to improve retention. Participants who feel informed, supported and respected are more likely to remain engaged through study completion, which directly influences data quality and trial continuity.
The maturity level of operations also represents a distinguishing factor. Established medical research providers can minimize burden for sponsors through ongoing personnel training, regulatory understanding, knowledge of electronic data capture systems, ability to review protocols and logistic support. These may sound administrative but the operational aspect may either result in an easier or more problematic trial in the long run.
Equally important is the ability to decline unsuitable studies. Disciplined providers understand that not every protocol aligns with their patient population, staffing structure or therapeutic expertise. The organizations that are selective about allowing studies will build stronger relationships with sponsor because their focus is on the quality of execution rather than the quantity of studies. This type of transparency is very useful to sponsor managing intricate protocol that enrollment must be consistent and study must be conducted carefully.
Community credibility also plays a major role in modern clinical research. Long-term provider relationships, local trust and repeat participant engagement frequently influence whether studies maintain enrollment momentum over time. Research organizations embedded within their communities often reach patient populations that might otherwise remain disconnected from clinical trial opportunities.
For sponsors, this means the strongest research partners combine operational speed with genuine local access and participant trust. ERA Health Research aligns well with these priorities for organizations seeking dependable clinical research execution. The company supports Phase I through Phase IV clinical research programs, including pharmacokinetics, pharmacodynamics, medical device studies, regulatory affairs, EDC support, scientific advisory services, protocol review, protocol design and clinical trial logistics planning.
Its operational model is reinforced by full-time principal investigators, dedicated nurse recruiters, an extensive participant database and established provider referral relationships across growing operations in Washington and Texas. For sponsors focused on faster study activation, qualified enrollment, transparent study evaluation and consistent trial management, ERA Health Research offers the combination of execution discipline and patient-access infrastructure increasingly required in clinical research today.
...Read more
Medical Research Services Info
Q1
What has positioned ERA Health Research among Top Medical Research Services providers?
Scientific discipline and patient-focused research capabilities have helped ERA Health Research gain recognition among Top Medical Research Services providers. The company supports clinical and healthcare research initiatives through structured study management, data collection and research coordination services. Its work emphasizes accuracy, regulatory alignment and efficient execution across medical research activities. This combination of research expertise and operational consistency has strengthened ERA Health Research’s role within medical research services.
Q2
How does ERA Health Research differentiate its research approach?
ERA Health Research emphasizes organized clinical research support built around scientific reliability and ethical study practices. Rather than relying on fragmented research workflows, the company structures its medical research services to support coordinated study execution, accurate documentation and dependable participant management. Its approach helps research programs maintain consistency across clinical activities while supporting quality data generation. This focus on research integrity gives ERA Health Research a differentiated presence within medical research services.
Q3
How does the company support healthcare and clinical research programs?
Successful clinical studies require dependable coordination, regulatory awareness and efficient research management. ERA Health Research supports medical research services through research administration, study oversight and participant-focused processes designed to improve trial execution. Its teams help maintain organized workflows while supporting communication between research stakeholders and clinical teams. By contributing to accurate and efficient study management, the company helps strengthen the overall quality of healthcare research initiatives.
Q4
What role does expertise play in ERA Health Research’s services?
Clinical knowledge and research experience remain central to the company’s service model. ERA Health Research applies scientific understanding and structured research practices to deliver medical research services that align with evolving healthcare and clinical study requirements. Its experience in managing research activities supports improved consistency across study processes and documentation standards. This expertise-driven approach enables the company to contribute effectively to complex medical and healthcare research environments.
Q5
How do medical research services create value through ERA Health Research?
Research value depends on reliable data generation, effective coordination and consistent study execution. ERA Health Research delivers medical research services that help organizations improve research efficiency, strengthen study accuracy and support informed healthcare decision-making. Its services also contribute to smoother clinical workflows and better management of research-related activities. This balance between scientific oversight and operational support increases the long-term value of the company’s research capabilities.
Q6
Why is ERA Health Research relevant to the future of healthcare research?
Healthcare research continues to evolve alongside growing demand for accurate clinical data and efficient study management. ERA Health Research contributes to this environment through medical research services focused on research quality, participant support and coordinated clinical operations. Its emphasis on structured study execution aligns with industry priorities surrounding healthcare advancement and evidence-based research. As clinical studies become increasingly specialized and data-driven, the company remains relevant to the future of medical research.
